Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A La Cava

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Lupus|February 14, 2009
Lupus and T cellsA La Cava
Lupus|May 21, 2008
T-regulatory cells in systemic lupus erythematosusA La Cava
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2011
Lupus, the current therapeutic approachesM Wong, A La Cava
Protein Expression and Purification|March 29, 2000
Genetic immunization for the recovery and purification of recombinant proteinsA La Cava, S Albani
Current Directions in Autoimmunity|January 17, 2002
The role of cytokines in autoimmunityA La Cava, N Sarvetnick
Tissue Antigens|July 6, 2007
Leptin in autoimmunity: many questions, some answersG Matarese, E H Leiter, A La Cava
International Reviews of Immunology|January 1, 1997
B-cell superantigens: molecular and cellular implicationsG J Silverman, J V Nayak, A La Cava
Current Medicinal Chemistry|November 12, 2009
The Yin and Yang of CD4(+) regulatory T cells in autoimmunity and cancerM Galgani, A Di Giacomo, G Matarese, et al.
Recent Patents on Inflammation & Allergy Drug Discovery|July 15, 2009
Leptin as clinical targetC Cai, F D Shi, G Matarese, et al.
Genes and Immunity|February 18, 2011
Interferon-inducible gene 202b controls CD8(+) T cell-mediated suppression in anti-DNA Ig peptide-treated (NZB × NZW) F1 lupus miceR Dinesh, B H Hahn, A La Cava, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Lupus|February 14, 2009
Lupus and T cellsA La Cava
Lupus|May 21, 2008
T-regulatory cells in systemic lupus erythematosusA La Cava
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2011
Lupus, the current therapeutic approachesM Wong, A La Cava
Protein Expression and Purification|March 29, 2000
Genetic immunization for the recovery and purification of recombinant proteinsA La Cava, S Albani
Current Directions in Autoimmunity|January 17, 2002
The role of cytokines in autoimmunityA La Cava, N Sarvetnick
Tissue Antigens|July 6, 2007
Leptin in autoimmunity: many questions, some answersG Matarese, E H Leiter, A La Cava
International Reviews of Immunology|January 1, 1997
B-cell superantigens: molecular and cellular implicationsG J Silverman, J V Nayak, A La Cava
Current Medicinal Chemistry|November 12, 2009
The Yin and Yang of CD4(+) regulatory T cells in autoimmunity and cancerM Galgani, A Di Giacomo, G Matarese, et al.
Recent Patents on Inflammation & Allergy Drug Discovery|July 15, 2009
Leptin as clinical targetC Cai, F D Shi, G Matarese, et al.
Genes and Immunity|February 18, 2011
Interferon-inducible gene 202b controls CD8(+) T cell-mediated suppression in anti-DNA Ig peptide-treated (NZB × NZW) F1 lupus miceR Dinesh, B H Hahn, A La Cava, et al.
Pageof 3